Bio-Rad Laboratories, Inc. Class A Common Stock vs Google Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Google Inc trades at $345.17 (market cap $4.20T). The key difference: Google Inc is far larger — about 445.4× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Google Inc pays a 0.26% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | GOOG | |
|---|---|---|
Market Cap | $9.43B | $4.20T |
Sector | Health | Technology |
52-Week High | $356.25 | $399.06 |
52-Week Low | $241.71 | $200.19 |
Enterprise Value | $9.18B | $4.09T |
Volume | — | 1,511,127 |
Dividend Yield | — | 0.26% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →